Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Zanen

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Clinical Biochemistry|January 19, 2016
The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseasesAdrian Kruit, Pieter Zanen
Statistics in Medicine|November 19, 2002
Selecting the best method to evaluate bronchodilation when analysing bronchodilator studiesDick M Goedhart, Pieter Zanen
Chest|November 13, 2004
Diffusion capacity for nitric oxide and carbon monoxideIvo van der Lee, Pieter Zanen
Chest|January 2, 2013
ResponseFirdaus A A Mohamed Hoesein, Pieter Zanen
Annals of the American Thoracic Society|May 2, 2017
Don't Forget Symptomatic Smokers without Airflow ObstructionFirdaus A A Mohamed Hoesein, Pieter Zanen
The European Respiratory Journal|January 2, 2014
Predicting an accelerated lung function decline in smokers: is there a proper threshold?Firdaus A A Mohamed Hoesein, Pieter Zanen
Respiratory Medicine|June 9, 2005
Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive diseasePieter Zanen, Hans Folgering, Jan-Willem J Lammers
Physiological Measurement|April 11, 2006
A comparison of lung function equipment with emphasis on interchangeability and methodsPaul Munnik, Pieter Zanen, Jan-Willem J Lammers
COPD|December 21, 2006
Relevant and redundant lung function parameters in discriminating asthma from COPDDick M Goedhart, Pieter Zanen, Jan-Willem J Lammers
Controlled Clinical Trials|December 14, 2004
Analyzing bronchodilation with emphasis on disease type, age and sexDick M Goedhart, Pieter Zanen, Jan-Willem J Lammers
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Clinical Biochemistry|January 19, 2016
The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseasesAdrian Kruit, Pieter Zanen
Statistics in Medicine|November 19, 2002
Selecting the best method to evaluate bronchodilation when analysing bronchodilator studiesDick M Goedhart, Pieter Zanen
Chest|November 13, 2004
Diffusion capacity for nitric oxide and carbon monoxideIvo van der Lee, Pieter Zanen
Chest|January 2, 2013
ResponseFirdaus A A Mohamed Hoesein, Pieter Zanen
Annals of the American Thoracic Society|May 2, 2017
Don't Forget Symptomatic Smokers without Airflow ObstructionFirdaus A A Mohamed Hoesein, Pieter Zanen
The European Respiratory Journal|January 2, 2014
Predicting an accelerated lung function decline in smokers: is there a proper threshold?Firdaus A A Mohamed Hoesein, Pieter Zanen
Respiratory Medicine|June 9, 2005
Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive diseasePieter Zanen, Hans Folgering, Jan-Willem J Lammers
Physiological Measurement|April 11, 2006
A comparison of lung function equipment with emphasis on interchangeability and methodsPaul Munnik, Pieter Zanen, Jan-Willem J Lammers
COPD|December 21, 2006
Relevant and redundant lung function parameters in discriminating asthma from COPDDick M Goedhart, Pieter Zanen, Jan-Willem J Lammers
Controlled Clinical Trials|December 14, 2004
Analyzing bronchodilation with emphasis on disease type, age and sexDick M Goedhart, Pieter Zanen, Jan-Willem J Lammers
Pageof 9